Aprogen Biologics Inc. (KRX: 003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
909.00
+4.00 (0.44%)
Oct 11, 2024, 3:30 PM KST
-66.59%
Market Cap 179.79B
Revenue (ttm) 73.64B
Net Income (ttm) -131.14B
Shares Out 197.57M
EPS (ttm) -1,977.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,360,136
Open 912.00
Previous Close 905.00
Day's Range 909.00 - 947.00
52-Week Range 875.00 - 3,890.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira... [Read more]

Sector Healthcare
Founded 1960
Employees 377
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.